1. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975–2009 (Vintage 2009 Populations), National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2009_pops09/, based on November 2011 SEER data submission, posted to the SEER web site, April 2012.
2. Androgen deprivation therapy for prostate cancer;Sharifi;JAMA,2005
3. Critical evaluation of hormonal therapy for carcinoma of the prostate;Chodak;Urology,2002
4. Increasing use of gonadotropin‐releasing hormone agonists for the treatment of localized prostate carcinoma;Shahinian;Cancer,2005
5. National practice patterns and time trends in androgen ablation for localized prostate cancer;Cooperberg;J Natl Cancer Inst,2003